Shalby, 540797, SHALBY Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,201.78
65.76
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,570.69
0.59%
2.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.99
13.91
10.14

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.21
16.62
8.00

PAT CAGR (%)

10 Years
5 Years
3 Years

12.57
24.96
15.82

P:E (Median)

8 Years
5 Years
3 Years

34.79
30.19
31.25

P:BV (Average)

8 Years
5 Years
3 Years

2.17
1.98
2.27

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.10
13.45
13.44

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 220.64 195.15 13.06% 212.27 217.09 -2.22% 232.72 211.12 10.23% 206.32 177.41 16.30%
Expenses 178.11 151.94 17.22% 176.81 165.35 6.93% 182.19 166.55 9.39% 168.07 147.48 13.96%
EBITDA 42.53 43.21 -1.57% 35.46 51.74 -31.47% 50.53 44.57 13.37% 38.26 29.93 27.83%
EBIDTM 19.27% 22.14% 16.71% 23.83% 21.71% 21.11% 18.54% 16.87%
Other Income 6.28 5.21 20.54% 5.29 5.75 -8.00% 7.52 5.17 45.45% 4.37 6.55 -33.28%
Interest 3.09 0.61 406.56% 2.69 0.73 268.49% 2.67 0.55 385.45% 0.99 0.69 43.48%
Depreciation 9.94 9.33 6.54% 9.78 9.43 3.71% 9.54 9.19 3.81% 9.12 9.30 -1.94%
PBT 35.77 38.48 -7.04% 28.28 47.33 -40.25% 45.84 39.99 14.63% 32.52 26.49 22.76%
Tax 14.91 13.76 8.36% 10.95 16.93 -35.32% 15.37 13.82 11.22% 9.96 8.14 22.36%
PAT 20.86 24.72 -15.61% 17.33 30.39 -42.97% 30.47 26.17 16.43% 22.56 18.35 22.94%
PATM 9.45% 12.67% 8.17% 14.00% 13.09% 12.40% 10.93% 10.35%
EPS 1.93 2.29 -15.72% 1.60 2.81 -43.06% 2.82 2.42 16.53% 2.09 1.70 22.94%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 275.63 216.05 27.58% 267.54 237.98 12.42% 278.89 235.48 18.43% 244.23 198.98 22.74%
Expenses 241.73 173.72 39.15% 234.89 185.26 26.79% 233.68 192.36 21.48% 205.37 173.32 18.49%
EBITDA 33.91 42.33 -19.89% 32.65 52.72 -38.07% 45.21 43.13 4.82% 38.87 25.66 51.48%
EBIDTM 12.30% 19.59% 12.20% 22.15% 16.21% 18.32% 15.91% 12.89%
Other Income 5.42 4.52 19.91% 7.16 5.38 33.09% 9.70 4.53 114.13% 4.99 9.18 -45.64%
Interest 10.66 3.63 193.66% 9.26 3.17 192.11% 8.12 2.75 195.27% 6.47 2.84 127.82%
Depreciation 16.32 12.40 31.61% 16.84 12.30 36.91% 16.37 11.94 37.10% 15.60 12.81 21.78%
PBT 12.35 30.81 -59.92% 13.70 42.63 -67.86% 30.41 32.97 -7.76% 21.78 19.19 13.50%
Tax 15.34 11.75 30.55% 11.34 15.06 -24.70% 15.67 12.15 28.97% 5.74 5.29 8.51%
PAT -2.99 19.06 - 2.36 27.58 -91.44% 14.74 20.82 -29.20% 16.04 13.90 15.40%
PATM -1.09% 8.82% 0.88% 11.59% 5.28% 8.84% 6.57% 6.99%
EPS -0.17 1.78 - 0.32 2.57 -87.55% 1.42 1.94 -26.80% 1.55 1.30 19.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 871.95 829.68 708.02 646.79 418.67 483.89 462.41 380.29 322.39 286.85 262.76 Net Sales Growth 8.89% 17.18% 9.47% 54.49% -13.48% 4.65% 21.59% 17.96% 12.39% 9.17% Cost Of Goods Sold 11.52 10.12 8.69 9.49 7.37 11.69 8.73 7.52 5.28 4.26 3.44 Gross Profit 860.43 819.57 699.33 637.31 411.31 472.20 453.68 372.77 317.10 282.58 259.32 GP Margin 98.68% 98.78% 98.77% 98.53% 98.24% 97.58% 98.11% 98.02% 98.36% 98.51% 98.69% Total Expenditure 705.18 650.69 564.72 515.54 331.63 401.33 378.88 300.39 249.75 229.15 193.21 Power & Fuel Cost - 17.73 16.23 14.49 12.31 12.95 12.64 9.33 7.40 6.55 4.74 % Of Sales - 2.14% 2.29% 2.24% 2.94% 2.68% 2.73% 2.45% 2.30% 2.28% 1.80% Employee Cost - 99.53 86.76 78.32 55.74 65.25 64.35 44.80 37.69 27.13 16.82 % Of Sales - 12.00% 12.25% 12.11% 13.31% 13.48% 13.92% 11.78% 11.69% 9.46% 6.40% Manufacturing Exp. - 479.82 420.68 382.25 235.78 280.06 271.27 214.88 180.62 174.87 157.47 % Of Sales - 57.83% 59.42% 59.10% 56.32% 57.88% 58.66% 56.50% 56.03% 60.96% 59.93% General & Admin Exp. - 39.83 29.69 19.75 13.32 19.61 18.89 20.35 17.10 15.31 9.05 % Of Sales - 4.80% 4.19% 3.05% 3.18% 4.05% 4.09% 5.35% 5.30% 5.34% 3.44% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 3.66 2.67 11.24 7.13 11.78 3.01 3.52 1.65 1.03 0.00 % Of Sales - 0.44% 0.38% 1.74% 1.70% 2.43% 0.65% 0.93% 0.51% 0.36% 0.65% EBITDA 166.78 178.99 143.30 131.25 87.04 82.56 83.53 79.90 72.64 57.70 69.55 EBITDA Margin 19.13% 21.57% 20.24% 20.29% 20.79% 17.06% 18.06% 21.01% 22.53% 20.12% 26.47% Other Income 23.46 20.70 19.57 13.00 9.62 17.74 9.37 9.63 6.04 2.37 3.02 Interest 9.44 4.32 4.44 4.40 4.50 7.41 9.16 12.14 10.65 10.26 5.43 Depreciation 38.38 37.08 37.06 35.50 36.67 35.86 33.00 22.43 16.01 10.63 20.07 PBT 142.41 158.31 121.36 104.36 55.49 57.03 50.73 54.95 52.02 39.17 47.06 Tax 51.19 54.47 40.55 30.11 12.61 29.06 18.62 14.49 21.66 -0.37 18.59 Tax Rate 35.95% 34.41% 33.41% 30.13% 22.72% 50.96% 36.70% 26.37% 41.64% -0.94% 39.50% PAT 91.22 103.84 80.81 69.81 42.88 27.97 32.10 40.47 30.36 39.53 28.47 PAT before Minority Interest 91.22 103.84 80.81 69.81 42.88 27.97 32.10 40.47 30.36 39.53 28.47 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.46% 12.52% 11.41% 10.79% 10.24% 5.78% 6.94% 10.64% 9.42% 13.78% 10.83% PAT Growth -8.44% 28.50% 15.76% 62.80% 53.31% -12.87% -20.68% 33.30% -23.20% 38.85% EPS 8.45 9.61 7.48 6.46 3.97 2.59 2.97 3.75 2.81 3.66 2.64

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,066.29 933.75 804.92 698.95 430.90 486.85 462.26 377.99 323.77 290.41 275.42 Net Sales Growth 20.01% 16.01% 15.16% 62.21% -11.49% 5.32% 22.29% 16.75% 11.49% 5.44% Cost Of Goods Sold 94.85 63.57 58.73 30.77 34.70 52.93 39.34 38.87 36.23 4.45 4.45 Gross Profit 971.44 870.18 746.19 668.18 396.20 433.92 422.91 339.12 287.54 285.95 270.97 GP Margin 91.10% 93.19% 92.70% 95.60% 91.95% 89.13% 91.49% 89.72% 88.81% 98.46% 98.38% Total Expenditure 915.67 755.13 666.75 577.38 343.57 404.06 378.78 299.05 252.28 234.84 207.86 Power & Fuel Cost - 19.70 16.25 14.49 12.31 12.98 12.66 9.43 7.59 6.79 5.35 % Of Sales - 2.11% 2.02% 2.07% 2.86% 2.67% 2.74% 2.49% 2.34% 2.34% 1.94% Employee Cost - 155.44 143.64 114.74 56.96 65.50 64.60 45.08 38.90 28.92 19.84 % Of Sales - 16.65% 17.85% 16.42% 13.22% 13.45% 13.97% 11.93% 12.01% 9.96% 7.20% Manufacturing Exp. - 444.54 382.26 368.79 217.63 240.98 239.99 180.67 149.77 177.68 166.36 % Of Sales - 47.61% 47.49% 52.76% 50.51% 49.50% 51.92% 47.80% 46.26% 61.18% 60.40% General & Admin Exp. - 66.80 61.34 35.38 13.60 19.83 19.07 20.56 17.58 15.91 10.12 % Of Sales - 7.15% 7.62% 5.06% 3.16% 4.07% 4.13% 5.44% 5.43% 5.48% 3.67% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 5.08 4.51 13.21 8.38 11.86 3.12 4.43 2.21 1.08 0.00 % Of Sales - 0.54% 0.56% 1.89% 1.94% 2.44% 0.67% 1.17% 0.68% 0.37% 0.63% EBITDA 150.64 178.62 138.17 121.57 87.33 82.79 83.48 78.94 71.49 55.57 67.56 EBITDA Margin 14.13% 19.13% 17.17% 17.39% 20.27% 17.01% 18.06% 20.88% 22.08% 19.14% 24.53% Other Income 27.27 19.43 22.52 12.42 9.06 17.37 9.26 10.01 6.75 2.15 2.21 Interest 34.51 17.62 10.56 7.53 4.54 7.41 9.18 12.37 11.04 10.45 5.49 Depreciation 65.13 52.24 48.09 42.87 36.80 36.02 33.17 22.86 16.70 11.33 21.24 PBT 78.24 128.19 102.04 83.58 55.05 56.73 50.39 53.73 50.50 35.92 43.03 Tax 48.09 44.69 34.37 25.18 12.69 29.14 18.73 14.56 21.80 -0.40 18.48 Tax Rate 61.46% 34.86% 33.68% 31.82% 23.05% 51.37% 37.17% 27.10% 43.17% -1.11% 42.95% PAT 30.15 84.08 67.70 54.12 42.40 27.59 31.66 39.38 29.69 37.58 25.73 PAT before Minority Interest 33.48 83.50 67.68 53.97 42.36 27.59 31.65 39.17 28.70 36.32 24.55 Minority Interest 3.33 0.58 0.02 0.15 0.04 0.00 0.01 0.21 0.99 1.26 1.18 PAT Margin 2.83% 9.00% 8.41% 7.74% 9.84% 5.67% 6.85% 10.42% 9.17% 12.94% 9.34% PAT Growth -62.94% 24.19% 25.09% 27.64% 53.68% -12.86% -19.60% 32.64% -21.00% 46.06% EPS 2.79 7.79 6.27 5.01 3.93 2.55 2.93 3.65 2.75 3.48 2.38

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,062.18 970.32 906.72 849.65 813.79 794.03 765.26 258.54 212.29 172.24 Share Capital 107.41 107.31 108.01 108.01 108.01 108.01 108.01 87.41 87.89 35.37 Total Reserves 953.95 862.20 798.71 741.64 705.78 686.02 657.25 170.86 124.40 136.87 Non-Current Liabilities 314.17 199.65 171.77 149.97 144.56 130.30 134.73 290.89 206.58 89.55 Secured Loans 103.12 14.61 25.33 35.50 48.67 56.91 75.44 235.45 151.12 73.73 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 49.95 49.95 0.00 Long Term Provisions 113.50 111.69 91.11 71.73 61.90 62.77 57.37 1.52 0.78 0.35 Current Liabilities 108.16 105.00 97.31 82.37 83.25 90.82 143.00 194.83 86.13 85.20 Trade Payables 72.77 72.77 61.31 59.49 60.34 58.81 49.31 39.18 44.97 57.78 Other Current Liabilities 32.57 30.85 29.95 22.34 22.19 31.36 53.42 62.13 34.53 20.37 Short Term Borrowings 0.00 0.00 5.00 0.00 0.00 0.00 15.72 22.97 6.48 7.00 Short Term Provisions 2.82 1.38 1.05 0.54 0.72 0.65 24.55 70.55 0.16 0.04 Total Liabilities 1,484.51 1,274.97 1,175.80 1,081.99 1,041.60 1,015.15 1,042.99 744.26 505.00 346.99 Net Block 599.28 602.83 628.18 657.58 669.82 689.06 647.34 312.20 308.61 144.10 Gross Block 850.53 817.11 805.54 802.16 778.68 762.71 688.09 329.04 407.94 258.22 Accumulated Depreciation 251.25 214.28 177.37 144.58 108.86 73.66 40.75 16.84 99.34 114.12 Non Current Assets 1,052.68 862.05 818.49 804.79 800.95 808.70 798.92 580.82 437.74 282.71 Capital Work in Progress 5.24 10.05 5.74 7.52 6.39 3.35 46.78 220.93 82.19 90.72 Non Current Investment 280.82 74.90 36.60 11.79 10.65 10.61 8.68 9.41 9.40 26.11 Long Term Loans & Adv. 166.01 172.74 145.41 120.30 110.72 101.95 95.84 38.01 37.38 21.45 Other Non Current Assets 1.33 1.53 2.57 7.61 3.37 3.72 0.28 0.27 0.16 0.33 Current Assets 431.82 412.93 357.31 277.20 240.65 206.46 244.07 163.44 67.26 64.28 Current Investments 230.65 237.89 25.49 20.32 32.10 13.41 1.35 0.43 0.00 0.00 Inventories 17.48 17.90 19.83 19.94 14.76 12.64 11.88 7.56 7.34 5.13 Sundry Debtors 117.71 89.64 94.30 93.00 91.49 81.33 50.38 33.46 30.67 20.32 Cash & Bank 9.23 3.32 104.39 82.97 28.71 25.34 115.11 15.70 15.36 29.59 Other Current Assets 56.76 5.37 27.90 24.12 73.59 73.73 65.34 106.30 13.90 9.24 Short Term Loans & Adv. 51.22 58.80 85.40 36.86 51.98 51.13 35.32 92.56 9.31 4.17 Net Current Assets 323.66 307.92 260.01 194.83 157.41 115.63 101.07 -31.39 -18.87 -20.92 Total Assets 1,484.50 1,274.98 1,175.80 1,081.99 1,041.60 1,015.16 1,042.99 744.26 505.00 346.99

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,000.37 927.69 876.33 834.66 799.16 779.79 751.46 251.41 205.02 168.43 Share Capital 107.41 107.31 108.01 108.01 108.00 108.01 108.01 87.41 87.89 35.37 Total Reserves 892.14 819.56 768.32 726.65 691.16 671.78 643.45 163.72 117.14 133.05 Non-Current Liabilities 387.83 269.47 233.60 150.04 144.41 130.13 140.01 290.88 206.82 90.20 Secured Loans 175.84 67.42 87.39 35.50 48.67 56.91 75.44 235.45 151.12 73.73 Unsecured Loans 0.13 0.00 0.00 0.00 0.00 0.00 0.00 49.95 49.95 0.00 Long Term Provisions 115.57 112.70 91.54 71.96 61.90 62.77 57.58 1.52 0.90 0.56 Current Liabilities 323.26 194.38 172.46 81.75 83.26 88.41 138.47 199.32 91.70 90.38 Trade Payables 129.57 87.92 70.73 57.60 60.16 56.27 49.17 39.23 46.78 61.42 Other Current Liabilities 86.51 55.91 57.14 23.58 22.37 31.48 48.78 63.26 35.43 21.39 Short Term Borrowings 103.96 49.10 43.49 0.00 0.00 0.00 15.72 26.07 9.32 7.52 Short Term Provisions 3.22 1.45 1.09 0.57 0.73 0.65 24.80 70.77 0.17 0.05 Total Liabilities 1,718.87 1,391.47 1,282.25 1,066.47 1,026.88 998.38 1,030.00 740.99 503.91 351.34 Net Block 966.21 685.17 675.40 659.56 672.48 691.88 650.32 323.01 319.28 175.07 Gross Block 1,285.02 909.84 860.19 804.16 782.09 766.12 691.50 340.55 427.87 300.14 Accumulated Depreciation 318.81 224.67 184.79 144.60 109.61 74.25 41.17 17.54 108.59 125.07 Non Current Assets 1,166.64 874.22 833.38 795.34 793.15 801.08 794.26 582.34 439.76 288.72 Capital Work in Progress 15.38 10.54 5.77 7.52 6.39 3.35 46.78 220.93 82.19 90.72 Non Current Investment 0.00 0.00 0.00 0.11 0.11 0.11 0.11 0.11 0.11 0.11 Long Term Loans & Adv. 180.02 175.95 148.21 120.55 110.80 102.02 96.76 38.01 37.99 22.50 Other Non Current Assets 5.03 2.56 4.01 7.61 3.37 3.72 0.28 0.27 0.18 0.33 Current Assets 552.25 517.25 442.26 271.12 233.73 197.29 235.73 158.65 64.16 62.62 Current Investments 80.64 145.72 24.70 15.52 27.88 10.78 0.00 0.00 0.00 0.00 Inventories 235.20 185.41 121.12 23.05 15.22 12.81 12.05 7.65 7.49 5.82 Sundry Debtors 144.63 106.37 100.99 94.69 94.86 81.36 50.88 33.63 31.43 21.55 Cash & Bank 27.22 12.29 110.56 83.59 28.73 25.40 115.90 15.85 16.07 31.00 Other Current Assets 64.55 5.46 14.55 17.59 67.04 66.95 56.90 101.52 9.17 4.25 Short Term Loans & Adv. 55.25 62.02 70.34 36.68 51.87 49.22 34.83 89.68 5.88 1.10 Net Current Assets 228.99 322.87 269.81 189.37 150.47 108.89 97.26 -40.67 -27.54 -27.76 Total Assets 1,718.89 1,391.47 1,275.64 1,066.46 1,026.88 998.37 1,029.99 740.99 503.92 351.34

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 139.77 164.53 100.93 77.24 57.09 45.54 15.20 71.44 7.09 128.60 PBT 158.31 121.36 99.92 55.49 57.03 50.73 54.95 52.02 39.17 47.06 Adjustment 26.31 27.59 41.29 36.75 36.82 35.74 32.18 24.43 15.48 23.65 Changes in Working Capital -25.09 42.65 -17.48 -5.75 -16.75 -30.83 -60.21 5.64 -37.47 69.17 Cash after chg. in Working capital 159.54 191.60 123.74 86.49 77.11 55.63 26.93 82.09 17.18 139.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.77 -27.07 -22.81 -9.24 -20.02 -10.10 -11.73 -10.65 -10.09 -11.28 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -206.01 -172.40 -40.32 -51.83 -32.28 -0.04 -241.78 -157.46 -147.81 -154.09 Net Fixed Assets -28.61 -15.88 -1.60 -24.61 -19.01 -31.19 -184.90 -59.84 -141.19 -147.09 Net Investments -198.68 -250.70 -29.98 10.64 -18.73 -13.99 -0.19 -0.44 16.71 -7.09 Others 21.28 94.18 -8.74 -37.86 5.46 45.14 -56.69 -97.18 -23.33 0.09 Cash from Financing Activity 72.14 -38.21 -17.25 -27.82 -21.50 -51.26 225.52 89.34 122.85 46.66 Net Cash Inflow / Outflow 5.91 -46.09 43.36 -2.41 3.31 -5.76 -1.06 3.32 -17.87 21.18 Opening Cash & Equivalents 3.30 49.39 6.02 8.44 5.12 10.88 11.58 8.26 26.13 4.96 Closing Cash & Equivalent 9.20 3.30 49.39 6.02 8.44 5.12 10.88 11.58 8.26 26.13

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 19.59 67.78 18.92 79.15 55.37 43.40 13.94 60.45 4.57 123.24 PBT 128.19 102.04 79.15 55.05 56.73 50.39 53.73 50.50 35.92 43.03 Adjustment 51.43 39.94 53.48 37.57 36.86 35.73 33.46 26.11 16.86 25.69 Changes in Working Capital -139.96 -45.80 -90.73 -4.38 -18.06 -33.32 -60.72 -5.56 -38.09 65.96 Cash after chg. in Working capital 39.66 96.18 41.90 88.25 75.53 52.79 26.47 71.04 14.70 134.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -20.06 -28.40 -22.98 -9.10 -20.16 -9.39 -12.54 -10.60 -10.13 -11.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 38.07 -61.08 -60.30 -51.27 -30.67 1.39 -236.51 -153.30 -98.02 -62.33 Net Fixed Assets -28.61 -15.88 -1.60 -24.61 -19.01 -31.19 -184.90 -59.84 -141.19 -147.09 Net Investments -198.68 -250.70 -29.98 10.64 -18.73 -13.99 -0.19 -0.44 16.71 -7.09 Others 265.36 205.50 -28.72 -37.30 7.07 46.57 -51.42 -93.02 26.46 91.85 Cash from Financing Activity -150.69 -50.01 90.46 -29.86 -21.50 -51.25 222.22 95.64 74.91 -38.99 Net Cash Inflow / Outflow -93.03 -43.31 49.07 -1.98 3.21 -6.45 -0.36 2.78 -18.55 21.92 Opening Cash & Equivalents 12.24 55.55 6.48 8.46 5.26 11.71 11.70 8.91 27.46 5.54 Closing Cash & Equivalent 27.18 12.24 55.55 6.48 8.46 5.26 11.71 11.70 8.91 27.46

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 98.81 90.35 83.95 78.66 75.34 73.51 70.85 29.55 24.24 49.17 ROA 7.53% 6.59% 6.18% 4.04% 2.72% 3.12% 4.53% 4.86% 9.28% 10.13% ROE 10.23% 8.61% 7.95% 5.16% 3.48% 4.12% 7.91% 12.92% 20.61% 17.94% ROCE 14.97% 12.94% 11.33% 6.78% 7.40% 6.87% 9.18% 12.33% 14.06% 23.18% Fixed Asset Turnover 1.00 0.87 0.80 0.53 0.63 0.64 0.75 0.87 0.86 1.15 Receivable days 45.61 47.41 52.85 80.42 65.18 51.98 40.24 36.30 32.44 23.72 Inventory Days 7.78 9.72 11.22 15.12 10.33 9.68 9.33 8.43 7.93 7.47 Payable days 2625.16 2816.74 2324.21 2970.32 53.62 50.49 53.79 61.97 83.85 68.36 Cash Conversion Cycle -2571.78 -2759.61 -2260.14 -2874.78 21.89 11.17 -4.22 -17.24 -43.47 -37.16 Total Debt/Equity 0.11 0.03 0.05 0.05 0.08 0.09 0.15 1.26 1.04 0.57 Interest Cover 37.69 28.31 23.73 13.33 8.70 6.53 5.53 5.88 4.82 9.66

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 93.06 86.37 81.13 77.28 74.00 72.20 69.57 28.73 23.41 48.08 ROA 5.37% 5.06% 4.60% 4.05% 2.72% 3.12% 4.42% 4.61% 8.49% 8.64% ROE 8.67% 7.51% 6.31% 5.19% 3.49% 4.13% 7.81% 12.60% 19.50% 15.92% ROCE 12.23% 10.72% 9.08% 6.85% 7.49% 6.94% 9.15% 12.21% 13.34% 21.84% Fixed Asset Turnover 0.85 0.91 0.84 0.54 0.63 0.63 0.73 0.84 0.80 1.04 Receivable days 49.06 47.01 51.09 80.28 66.06 52.21 40.80 36.67 33.29 24.21 Inventory Days 82.21 69.50 37.64 16.21 10.51 9.82 9.51 8.53 8.37 8.15 Payable days 624.41 492.96 761.23 619.39 52.03 49.27 54.08 62.80 86.10 68.79 Cash Conversion Cycle -493.14 -376.45 -672.49 -522.90 24.53 12.76 -3.77 -17.59 -44.44 -36.43 Total Debt/Equity 0.31 0.15 0.18 0.05 0.08 0.09 0.15 1.31 1.09 0.58 Interest Cover 8.28 10.66 11.51 13.13 8.66 6.49 5.34 5.58 4.44 8.83

Annual Reports:

News Update:

Shalby - Quarterly Results
3rd Feb 2025, 19:36 PM

Read More
Shalby launches Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad
16th Jan 2025, 15:57 PM

With this new venture, the company will be able to distribute bone grafts to hospitals, surgeons, and even direct-to-patient on a prescription basis
Read More
Shalby’s step down arm receives USFDA’s approval for Duraniom
16th Jan 2025, 11:09 AM

Based on the safety and effectiveness data, USFDA has determined the device is substantially equivalent to legally marketed predicate devices
Read More

Shalby Ltd.

Hospital & Healthcare Services

BSE: 540797 | NSE: SHALBY

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update:

Shalby Ltd.

Hospital & Healthcare Services

BSE: 540797 | NSE: SHALBY

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update: